Relay Therapeutics, Inc. (RLAY)
19.95
-0.44
(-2.16%)
USD |
NASDAQ |
Nov 10, 16:00
19.95
0.00 (0.00%)
After-Hours: 20:00
Relay Therapeutics Cash from Operations (Annual) : -235.46M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -235.46M |
| December 31, 2024 | -249.11M |
| December 31, 2023 | -300.32M |
| December 31, 2022 | -229.49M |
| Date | Value |
|---|---|
| December 31, 2021 | -74.41M |
| December 31, 2020 | -102.49M |
| December 31, 2019 | -66.13M |
| December 31, 2018 | -44.14M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| SELLAS Life Sciences Group, Inc. | -28.39M |
| TG Therapeutics, Inc. | -24.77M |
| Spyre Therapeutics, Inc. | -169.41M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |